Evelo Biosciences, Inc. (EVLO) financial statements (2022 and earlier)

Company profile

Business Address 620 MEMORIAL DRIVE
CAMBRIDGE, MA 02139
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
3/31/2021
Q1
12/31/2020
Q4
9/30/2020
Q3
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:68,44195,938123,300124,60068,85781,600
Cash and cash equivalents68,44195,938123,333124,59168,85781,580
Other undisclosed cash, cash equivalents, and short-term investments  (33)9 20
Restricted cash and investments  300300300 
Receivables   7,500  
Other undisclosed current assets2,5851,9772,7671,7811,8232,959
Total current assets:71,02697,915126,367134,18170,98084,559
Noncurrent Assets
Operating lease, right-of-use asset8,9109,3899,85610,31210,75711,192
Property, plant and equipment6,6227,7627,5207,2367,4787,586
Other noncurrent assets1,3131,3921,3151,3131,4241,500
Total noncurrent assets:16,84518,54318,69118,86119,65920,278
TOTAL ASSETS:87,871116,458145,058153,04290,639104,837
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities14,66918,15817,33015,57717,69611,552
Accounts payable1,6012,5172,3193801,4422,729
Accrued liabilities13,06815,64115,01115,19716,2548,823
Debt   2,6561,6741,607
Other liabilities742692654486463389
Other undisclosed current liabilities1,9511,8771,812   
Total current liabilities:17,36220,72719,79618,71919,83313,548
Noncurrent Liabilities
Long-term debt and lease obligation54,34254,89255,40638,72140,03740,427
Long-term debt, excluding current maturities46,55746,52046,48229,25830,04829,924
Operating lease, liability7,7858,3728,9249,4639,98910,503
Liabilities, other than long-term debt7,5007,7637,7637,763284432
Deferred revenue 7,5007,5007,500  
Deferred rent credit7,500     
Other liabilities 263263263284432
Total noncurrent liabilities:61,84262,65563,16946,48440,32140,859
Total liabilities:79,20483,38282,96565,20360,15454,407
Stockholders' equity
Stockholders' equity attributable to parent8,66733,07662,09387,83930,48550,430
Common stock545353534746
Additional paid in capital423,308419,066414,353408,501322,957313,853
Accumulated deficit(414,695)(386,043)(352,313)(320,715)(292,519)(263,469)
Total stockholders' equity:8,66733,07662,09387,83930,48550,430
TOTAL LIABILITIES AND EQUITY:87,871116,458145,058153,04290,639104,837

Income statement (P&L) ($ in thousands)

12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
3/31/2021
Q1
12/31/2020
Q4
9/30/2020
Q3
Operating expenses(27,559)(32,710)(27,656)(27,471)(28,198)(20,182)
Operating loss:(27,559)(32,710)(27,656)(27,471)(28,198)(20,182)
Nonoperating expense(996)(864)(3,889)(603)(664)(674)
Investment income, nonoperating(1,010)(1,023)(814)(765)(756)(713)
Other nonoperating income141591511629239
Interest and debt expense  (3,226)   
Other undisclosed income from continuing operations before equity method investments, income taxes  3,226   
Loss from continuing operations before income taxes:(28,555)(33,574)(31,545)(28,074)(28,862)(20,856)
Income tax expense(97)(156)(53)(122)(188)(67)
Net loss available to common stockholders, diluted:(28,652)(33,730)(31,598)(28,196)(29,050)(20,923)

Comprehensive Income ($ in thousands)

12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
3/31/2021
Q1
12/31/2020
Q4
9/30/2020
Q3
Net loss:(28,652)(33,730)(31,598)(28,196)(29,050)(20,923)
Comprehensive loss, net of tax, attributable to parent:(28,652)(33,730)(31,598)(28,196)(29,050)(20,923)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: